📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Anji Pharma

1.1 - Company Overview

Anji Pharma Logo

Anji Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.

Products and services

  • ANJ908 (Pradigastat): A DGAT1-targeted inhibitor addressing chronic idiopathic constipation by increasing bowel movement frequency and softer stools via altering the intestinal milieu
  • ANJ900: An engineered, gut-targeted metformin formulation for type 2 diabetes with advanced chronic kidney disease, lowering glucose while minimizing systemic exposure
  • Genetics-validated target strategy: A genetics-validated research emphasis on tackling high-value targets confirmed by human genetics

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Anji Pharma

EdenRoc Sciences Logo

EdenRoc Sciences

HQ: United States Website
  • Description: Provider of holding and operating services for bioscience and pharmaceutical startups, managing Metro International Biotech (proprietary NAD boosters), Cantata Bio (NGS-based multiomics tools via Dovetail Genomics and Arc Bio), Claret Bioscience, Astrea Forensics (advanced DNA for casework), Delavie Sciences (consumer care ingredients), and Liberty Biosecurity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EdenRoc Sciences company profile →
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical offerings focused on acquiring, developing, and commercializing branded prescription products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cumberland Pharmaceuticals company profile →
Meda Pharma Logo

Meda Pharma

HQ: United States Website
  • Description: Provider of pharmaceutical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Meda Pharma company profile →
Stada Logo

Stada

HQ: Germany Website
  • Description: Provider of pharmaceuticals and non-prescription consumer health products, operating on three pillars: OTC consumer healthcare, generics, and specialty pharmaceuticals. Sells products in over 120 countries, including acetaminophen, lactulose, Grippostad-C, Vitaprost, Cardiomagnyl, Xefocam Rapid, Aqualor, Edarbi, and Levomekol.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stada company profile →
Pharmion Logo

Pharmion

HQ: United States Website
  • Description: Provider of products for the treatment of hematology and oncology patients, focused on acquisition, development, and commercialization. Global biotech partnering with scientific and clinical advisors to identify and develop products for hematology and oncology markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmion company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Anji Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Anji Pharma

2.2 - Growth funds investing in similar companies to Anji Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Anji Pharma

4.2 - Public trading comparable groups for Anji Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Anji Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Anji Pharma

What does Anji Pharma do?

Anji Pharma is a provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.

Who are Anji Pharma's competitors?

Anji Pharma's competitors and similar companies include EdenRoc Sciences, Cumberland Pharmaceuticals, Meda Pharma, Stada, and Pharmion.

Where is Anji Pharma headquartered?

Anji Pharma is headquartered in United States.

How many employees does Anji Pharma have?

Anji Pharma has 1,000 employees 🔒.

When was Anji Pharma founded?

Anji Pharma was founded in 2010 🔒.

What sector and industry vertical is Anji Pharma in?

Anji Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Anji Pharma

Who are the top strategic acquirers in Anji Pharma's sector and industry

Top strategic M&A buyers and acquirers in Anji Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Anji Pharma?

Top strategic M&A buyers groups and sectors for Anji Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Anji Pharma's sector and industry vertical

Which are the top PE firms investing in Anji Pharma's sector and industry vertical?

Top PE firms investing in Anji Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Anji Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Anji Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Anji Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Anji Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Anji Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Anji Pharma?

The key public trading comparables and valuation benchmarks for Anji Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Anji Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Anji Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Anji Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Anji Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Anji Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Anji Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Anji Pharma

Launch login modal Launch register modal